MORGAN STANLEY

Holdings History for Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Symbol: INMB on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$191,120	122,512	+46,802	+62%	$1.56	Q4 2025
30 Sep 2025	0%	-0%	$156,720	75,710	-27,028	-26%	$2.07	Q3 2025
30 Jun 2025	0%	+0%	$237,324	102,738	+18,274	+22%	$2.31	Q2 2025
31 Mar 2025	0%	-0%	$659,663	84,464	-70,662		$7.81	Q1 2025
31 Dec 2024	0%	+0%	$724,439	155,126	+62,982		$4.67	Q4 2024
30 Sep 2024	0%	+0%	$496,656	92,144	+63,769	+200%	$5.39	Q3 2024
30 Jun 2024	0%	+0%	$250,268	28,375	+896		$8.82	Q2 2024
31 Mar 2024	0%	+0%	$322,879	27,479	+14,676	+115%	$11.75	Q1 2024
31 Dec 2023	0%	+0%	$144,162	12,803	+8,722	+214%	$11.26	Q4 2023
30 Sep 2023	0%	-0%	$27,629	4,081	-913	-18%	$6.77	Q3 2023
30 Jun 2023	0%	0%	$45,346	4,994	+177	+3.7%	$9.08	Q2 2023
31 Mar 2023	0%	+0%	$31,119	4,817	+1,829	+61%	$6.46	Q1 2023
31 Dec 2022	0%	-0%	$18,944	2,988	-126,012	-98%	$6.34	Q4 2022
30 Sep 2022	0%	-0%	$800,000	129,000	-79,282	-38%	$6.20	Q3 2022
30 Jun 2022	0%	-0%	$1,841,000	208,282	-92,196	-31%	$8.84	Q2 2022
31 Mar 2022	0%	-0%	$2,530,000	300,478	-77,969	-21%	$8.42	Q1 2022
31 Dec 2021	0%	+0%	$3,861,000	378,447	+353,816	+1436%	$10.20	Q4 2021
30 Sep 2021	0%	+0%	$478,000	24,631	+13,128	+114%	$19.41	Q3 2021
30 Jun 2021		0%	$1,000	40	0		$25.00 ^*	Q2 2021
30 Jun 2021	0%	+0%	$202,000	11,503	+8,410	+272%	$17.56	Q2 2021
31 Mar 2021	0%	+0%	$37,000	3,093	+1,526	+97%	$11.96	Q1 2021
31 Dec 2020	0%	+0%	$27,000	1,567	+567	+57%	$17.23	Q4 2020
30 Sep 2020	0%	+0%	$10,000	1,000	+1,000	NEW	$10.00	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.